Eastwood Bio-Medical Canada Inc
XTSX:EBM

Watchlist Manager
Eastwood Bio-Medical Canada Inc Logo
Eastwood Bio-Medical Canada Inc
XTSX:EBM
Watchlist
Price: 0.95 CAD 17.28% Market Closed
Market Cap: 65.4m CAD

Eastwood Bio-Medical Canada Inc
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Eastwood Bio-Medical Canada Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Eastwood Bio-Medical Canada Inc
XTSX:EBM
Cash from Operating Activities
CA$21.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Cash from Operating Activities
$1.5B
CAGR 3-Years
N/A
CAGR 5-Years
10%
CAGR 10-Years
-5%
Canopy Growth Corp
TSX:WEED
Cash from Operating Activities
-CA$88.4m
CAGR 3-Years
46%
CAGR 5-Years
34%
CAGR 10-Years
-23%
Sundial Growers Inc
NASDAQ:SNDL
Cash from Operating Activities
CA$69.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Cash from Operating Activities
$21.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Cash from Operating Activities
CA$35.6m
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Eastwood Bio-Medical Canada Inc
Glance View

Market Cap
65.4m CAD
Industry
Pharmaceuticals

Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. The company is headquartered in Richmond, British Columbia. The company went IPO on 2014-09-05. The firm is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients. The Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. The firm's licensed products include Eleotin A 700, which is a treatment for spleen deficiency, lack of appetite and fatigue; Eleotin AL88, a laxative; Eleotin Cal20, for bone and teeth maintenance; Eleotin V3D for the development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55, a sedative and tension relief, Eleotin Zn330, which is involved in tissue formation and metabolism; Eleotin Bentley, which is used to promote healthy glucose levels, and Eleotin LBM, which is recommended for hypertension relief.

EBM Intrinsic Value
0.03 CAD
Overvaluation 96%
Intrinsic Value
Price

See Also

What is Eastwood Bio-Medical Canada Inc's Cash from Operating Activities?
Cash from Operating Activities
21.1k CAD

Based on the financial report for Jul 31, 2025, Eastwood Bio-Medical Canada Inc's Cash from Operating Activities amounts to 21.1k CAD.

Back to Top